Literature DB >> 25434940

Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.

Eric Ojerholm1, John Y K Lee, Jayesh P Thawani, Denise Miller, Donald M O'Rourke, Jay F Dorsey, Geoffrey A Geiger, Suneel Nagda, James D Kolker, Robert A Lustig, Michelle Alonso-Basanta.   

Abstract

OBJECT: Following resection of a brain metastasis, stereotactic radiosurgery (SRS) to the cavity is an emerging alternative to postoperative whole-brain radiation therapy (WBRT). This approach attempts to achieve local control without the neurocognitive risks associated with WBRT. The authors aimed to report the outcomes of a large patient cohort treated with this strategy.
METHODS: A retrospective review identified 91 patients without a history of WBRT who received Gamma Knife (GK) SRS to 96 metastasis resection cavities between 2007 and 2013. Patterns of intracranial control were examined in the 86 cases with post-GK imaging. Survival, local failure, and distant failure were estimated by the Kaplan-Meier method. Prognostic factors were tested by univariate (log-rank test) and multivariate (Cox proportional hazards model) analyses.
RESULTS: Common primary tumors were non-small cell lung (43%), melanoma (14%), and breast (13%). The cases were predominantly recursive partitioning analysis Class I (25%) or II (70%). Median preoperative metastasis diameter was 2.8 cm, and 82% of patients underwent gross-total resection. A median dose of 16 Gy was delivered to the 50% isodose line, encompassing a median treatment volume of 9.2 cm(3). Synchronous intact metastases were treated in addition to the resection bed in 43% of cases. Patients survived a median of 22.3 months from the time of GK. Local failure developed in 16 cavities, for a crude rate of 18% and 1-year actuarial local control of 81%. Preoperative metastasis diameter ≥ 3 cm and residual or recurrent tumor at the time of GK were associated with local failure (p = 0.04 and 0.008, respectively). Distant intracranial failure occurred in 55 cases (64%) at a median of 7.3 months from GK. Salvage therapies included WBRT and additional SRS in 33% and 31% of patients, respectively. Leptomeningeal carcinomatosis developed in 12 cases (14%) and was associated with breast histology and infratentorial cavities (p = 0.024 and 0.012, respectively).
CONCLUSIONS: This study bolsters the existing evidence for SRS to the resection bed. Local control rates are high, but patients with larger preoperative metastases or residual/recurrent tumor at the time of SRS are more likely to fail at the cavity. While most patients develop distant intracranial failure, an SRS approach spared or delayed WBRT in the majority of cases. The risk of leptomeningeal carcinomatosis does not appear to be elevated with this strategy.

Entities:  

Keywords:  GK = Gamma Knife; GTR = gross-total resection; Gamma Knife; LMC = leptomeningeal carcinomatosis; RPA = recursive partitioning analysis; SRS = stereotactic radiosurgery; WBRT = whole-brain radiation therapy; leptomeningeal; resection bed; resection cavity; stereotactic radiosurgery

Mesh:

Year:  2014        PMID: 25434940     DOI: 10.3171/2014.6.GKS14708

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  40 in total

1.  Postoperative local fractionated radiotherapy for resected single brain metastases.

Authors:  Ahmad Walid Ayas; Stefan Grau; Karolina Jablonska; Daniel Ruess; Maximilian Ruge; Simone Marnitz; Roland Goldbrunner; Martin Kocher
Journal:  Strahlenther Onkol       Date:  2018-09-14       Impact factor: 3.621

2.  Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.

Authors:  Anthony L Asher; Mohammed Ali Alvi; Mohamad Bydon; Nader Pouratian; Ronald E Warnick; James McInerney; Inga S Grills; Jason Sheehan
Journal:  J Neurooncol       Date:  2021-01-22       Impact factor: 4.130

3.  Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.

Authors:  Kirtesh R Patel; Stuart H Burri; Danielle Boselli; James T Symanowski; Anthony L Asher; Ashley Sumrall; Robert W Fraser; Robert H Press; Jim Zhong; Richard J Cassidy; Jeffrey J Olson; Walter J Curran; Hui-Kuo G Shu; Ian R Crocker; Roshan S Prabhu
Journal:  J Neurooncol       Date:  2016-12-20       Impact factor: 4.130

4.  Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases.

Authors:  Ammoren E Dohm; Ryan Hughes; William Wheless; Michael Lecompte; Claire Lanier; Jimmy Ruiz; Kounosuke Watabe; Fei Xing; Jing Su; Christina Cramer; Adrian Laxton; Stephen Tatter; Michael D Chan
Journal:  J Neurooncol       Date:  2018-10-26       Impact factor: 4.130

5.  Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer.

Authors:  Daniel M Trifiletti; Kara D Romano; Zhiyuan Xu; Kelli A Reardon; Jason Sheehan
Journal:  J Neurooncol       Date:  2015-06-21       Impact factor: 4.130

Review 6.  Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship.

Authors:  Colette J Shen; Michael Lim; Lawrence R Kleinberg
Journal:  Curr Treat Options Oncol       Date:  2016-09

7.  Stereotactic Radiosurgery to Prevent Local Recurrence of Brain Metastasis After Surgery: Neoadjuvant Versus Adjuvant.

Authors:  Ian E McCutcheon
Journal:  Acta Neurochir Suppl       Date:  2021

8.  Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.

Authors:  Rosaline Ma; Morgan Levy; Bin Gui; Shou-En Lu; Venkat Narra; Sharad Goyal; Shabbar Danish; Simon Hanft; Atif J Khan; Jyoti Malhotra; Sabin Motwani; Salma K Jabbour
Journal:  J Neurooncol       Date:  2017-11-20       Impact factor: 4.130

9.  Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease.

Authors:  Paul M Foreman; Bradford E Jackson; Karan P Singh; Andrew K Romeo; Barton L Guthrie; Winfield S Fisher; Kristen O Riley; James M Markert; Christopher D Willey; Markus Bredel; John B Fiveash
Journal:  J Clin Neurosci       Date:  2017-12-14       Impact factor: 1.961

Review 10.  Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis.

Authors:  Joshua D Palmer; Jeffrey Greenspoon; Paul D Brown; Derek R Johnson; David Roberge
Journal:  Neurooncol Pract       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.